Description
Cefoperazone 1g + Tazobactam 125mg Injection
Farlex Critical Care offers Cefoperazone 1g + Tazobactam 125mg Injection, a potent combination antibiotic used to treat severe bacterial infections. Cefoperazone, a third-generation cephalosporin, provides broad-spectrum activity, while Tazobactam, a beta-lactamase inhibitor, enhances its effectiveness against resistant bacteria.
Our Cefoperazone 1g + Tazobactam 125mg Injection is produced in state-of-the-art facilities that comply with stringent quality standards, ensuring both safety and efficacy. As one of the leading Injectable Pharmaceutical Companies in India, Farlex Critical Care is dedicated to providing high-quality pharmaceutical products to healthcare professionals.
Key Benefits:
- Broad-Spectrum Efficacy: Effective against a wide range of bacterial infections.
- Enhanced Potency: Tazobactam prevents the breakdown of Cefoperazone by beta-lactamase enzymes.
- High-Quality Production: Manufactured in ISO and GMP certified facilities.
- Trusted Provider: Farlex Critical Care is a renowned name in the critical care pharmaceutical industry.
Applications:
Cefoperazone 1g + Tazobactam 125mg Injection is used to treat severe bacterial infections such as pneumonia, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Always consult a healthcare professional before use.
Why Choose Farlex Critical Care?
- We are a leading Injectable Pharmaceutical Company in India.
- We provide high-quality products and comprehensive support to healthcare professionals.
- Our commitment to excellence ensures the best possible treatments are available.
For more information or to collaborate with us, contact Farlex Critical Care today.
